Nobex Corporation
42Patents
0Active
42Granted
36Portfolio score
Filing activity: Jun 26, 1986 → Oct 29, 2004
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6309633A | Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same | Emerging Cross-Sectional Technologies | 135 | Expired |
| US6858580B2 | Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same | Human Necessities | 70 | Expired |
| US6703381B1 | Methods for delivery therapeutic compounds across the blood-brain barrier | Human Necessities | 67 | Expired |
| US7030084B2 | Drug-oligomer conjugates with polyethylene glycol components | Human Necessities | 59 | Expired |
| US6713454B1 | Prodrugs of etoposide and etoposide analogs | Human Necessities | 39 | Expired |
| US6583128B2 | Immunoregulatory compounds and derivatives and methods of treating diseases therewith | Emerging Cross-Sectional Technologies | 38 | Expired |
| US6903082B2 | Methods of treating inflammatory conditions of the gastrointestinal tract using 4-APAA and compositions thereof | Emerging Cross-Sectional Technologies | 32 | Expired |
| US6835802B2 | Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties | Chemistry; Metallurgy | 31 | Expired |
| US6815530B2 | Substantiallymonodispersed mixtures of polymers having polyethylene glycol moieties | Chemistry; Metallurgy | 29 | Expired |
| US6770625B2 | Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith | Human Necessities | 25 | Expired |
| US6867183B2 | Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith | Human Necessities | 24 | Expired |
| US7030082B2 | Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith | Human Necessities | 23 | Expired |
| US6458776B1 | 5-ASA derivatives having anti-inflammatory and antibiotic activity and methods of treating diseases therewith | Human Necessities | 21 | Expired |
| US6930090B2 | Methods of activating a receptor using amphiphilic drug-oligomer conjugates | Human Necessities | 20 | Expired |
| US6380405B1 | Taxane prodrugs | Emerging Cross-Sectional Technologies | 20 | Expired |
| US6541508B2 | Taxane prodrugs | Emerging Cross-Sectional Technologies | 19 | Expired |
| USD295825S | Mitre box | General | 17 | Expired |
| US7060675B2 | Methods of treating diabetes mellitus | Human Necessities | 16 | Expired |
| US6828297B2 | Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same | Human Necessities | 15 | Expired |
| US6479692B1 | Methods of synthesizing acylanilides including bicalutamide and derivatives thereof | Chemistry; Metallurgy | 11 | Expired |
| US6713452B2 | Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same | Human Necessities | 11 | Expired |
| US7119074B2 | Treatment of cancers, tumors and malignancies using amphiphilic prodrugs | Human Necessities | 10 | Expired |
| US7084114B2 | Mixtures of insulin drug-oligomer comprising polyalkylene glycol | Human Necessities | 10 | Expired |
| US7119162B2 | Substantially monodispersed mixtures of polymers having polyethylene glycol moieties | Chemistry; Metallurgy | 7 | Expired |
| US6436990B1 | 6-methoxy-2-naphthylacetic acid prodrugs | Human Necessities | 7 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.